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Abstract: Cell-based biosensing is a “smart” way to obtain efficacy-information on the 
effect of applied chemical on cellular biological cascade. We have proposed an engineered 
post-synapse  model  cell-based  biosensors  to  investigate  the  effects  of  chemicals  on 
ionotropic glutamate receptor (GluR), which is a focus of attention as a molecular target 
for clinical neural drug discovery. The engineered model cell has several advantages over 
native  cells,  including  improved  ease  of  handling  and  better  reproducibility  in  the 
application of cell-based biosensors. However, in general, cell-based biosensors often have 
low signal-to-noise (S/N) ratios due to the low level of cellular responses.  In order to 
obtain a higher S/N ratio in model cells, we have attempted to design a tactic model cell 
with elevated cellular response. We have revealed that the increase GluR expression level 
is not directly connected to the amplification of cellular responses because the saturation of 
surface  expression  of  GluR,  leading  to  a  limit  on  the  total  ion  influx.  Furthermore, 
coexpression of GluR with a voltage-gated potassium channel increased Ca
2+ ion influx 
beyond levels obtained with saturating amounts of GluR alone. The construction of model 
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cells  based on  strategy of  amplifying  ion  flux  per individual  receptors  can  be  used  to 
perform smart cell-based biosensing with an improved S/N ratio. 
Keywords: cell-based biosensors; high through-put analysis (HTA); organ function model; 
post-synapse model cell; cell engineering; ionotropic glutamate receptor; signal-to-noise ratio 
 
1. Introduction 
Cultured  mammalian  cell-based  biosensors  have  been  developed  to  determine  the  effects  of 
extracellular stimuli on cellular function in basic research fields, and drug discovery [1,2]. These are a 
smart way to screen lead compounds on the basis of their effects on metabolic/catabolic cascades [3–5]. 
However, in general, cell-based biosensors have low signal-to-noise (S/N) ratio due to the low signal 
of cellular responses. To solve this problem, not only must the sensitivity of sensors be improved but 
also the tactic biosensor cells need to be engineered using e.g., genetic engineering [6,7], cellular 
engineering [8,9], and cell culture engineering [5,10].  
A conjugative technology which combined with chemical sensors and organ function model has 
been proposed [4]. On the basis of this concept, we demonstrated a post-synaptic function model that 
consists of genetically engineered cells designed to minimize the fluctuation of data in cell-based assay 
for neural drug discovery [11]. The post-synapse model cells express ionotropic glutamate receptor 
(GluR)  on  their  membrane  surface.  As  such,  these  cells  can  recognize  either  the  agonistic  and 
antagonistic activity on the basis of a change in the ion flux profile [12]. In addition, our post-synapse 
model  cells  grow  faster  and  are  easier  to  handle  than  cultured  neuronal  cells  under  experimental 
conditions  [11].  Therefore,  these  model  cells  have  several  advantages  as  a  functional  model  for  
cell-based biosensors for high through-put analysis (HTA). 
Recently, many researchers have attempted to develop cell-based biosensors using receptor-expressing 
cells because receptors are one of the main targets for neural drug discovery [13,14]. However, owing 
to the low level of cellular signals, receptor-expressing cell-based biosensors often have low S/N ratio. 
In  order  to  improve  the  S/N  ratio  in  receptor-expressing  cell-based  biosensors,  it  is  important  to 
amplify the cellular responses.  
In the case of ionotropic receptor-expressing cells, the cellular response, i.e., ion flux on the whole 
cell, was controlled by the number of receptors on the  cell  membrane  and the ion flux level per 
individual receptor. Therefore, in order to amplify the cellular responses on receptor-expressing cells, 
one can increase either the receptor expression level or the ion flux level per individual receptors. In 
this study, we investigate and demonstrate a new design for post-synapse model cells realizing a high 
S/N ratio. The approach involves attempting to increase the ion flux level per individual receptor, 
which is directly linked to amplification of cellular responses (ion influx through GluR). 
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2. Experimental Section  
2.1. Chemicals 
L-Glutamic  acid  and  2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione  (NBQX), 
were  purchased  from  Wako  Chemical  (Tokyo,  Japan).  Margatoxin  was  purchased  from  Peptide 
Institute,  Inc  (Osaka,  Japan).  The  acetoxymethyl  form  of  Fura-2  was  purchased  from  Invitrogen 
(Carlsbad, CA, USA). All chemicals of guaranteed experimental grade. 
2.2. Cell Culture and Transfection 
COS7 cells were cultured in Dulbecco’s modified Eagles medium (DMEM) containing 10% FBS, 
100 U/mL penicillin, and 100 μg/mL streptomycin. Flag-tagged GluA4 (Δ22-402) [15], a miniaturized 
version of GluA4 receptor lacking the N-terminal domain, was constructed in pIRES2-EGFP vector 
(Clontech Laboratories, Mountain View, CA, USA) as described previously [11]. Rat voltage-gated 
Shaker potassium channel, Kv1.3 [16] was amplified by polymerase chain reaction. The amplicon was 
ligated to the XhoI and EcoRI sites using pIRES2-DsRed plasmid vector (Clontech). The expression 
plasmids were transfected into COS7 cells using Xfect
TM (Invitrogen). After transfection, the cells 
were  cultured  in  DMEM  with  10%  FBS,  100  U/mL  penicillin,  100  μg/mL  streptomycin.  NBQX  
(100 μM) was added in order to suppress the potential toxicity of glutamate present in the medium. 
2.3. Immuno-Fluorescence Staining 
The engineered cells were cultured on a fibronectin coated coverslips. The cells were fixed with 3% 
paraformaldehyde and used for immuno-staining (nonpermeabilized condition, surface staining). In the 
case of permeabilized condition, the cells were treated with 0.05% Triton-X solution in PBS after 
paraformaldehyde fixation. Nonspecific binding was blocked by incubation in SuperBlock blocking 
buffer (Pierce Biotechnology, Rockford, IL, USA). The cells were labeled with monoclonal rabbit  
anti-FLAG IgG (Sigma, St. Louis, MO, USA; 5 μg/mL) followed by rhodamine-conjugated anti-rabbit 
IgG  secondary  antibody  (Sigma;  7  μg/mL).  They  were  then  examined  using  an  epifluorescence 
microscope (Nikon, Japan). Pictures were collected using an air-cooled CCD camera and analyzed 
using the AQUA COSMOS software (Hamamatsu Photonics, Japan). 
2.4. Fluorescence Measurement of Ion Flux 
GluA4 channels are permeable to both sodium and calcium influxes by its agonistic function [17]. 
We monitored calcium influx using calcium ion indicator dye, Fura-2. The dye for post-synapse model 
cells was prepared and loaded as described previously [11]. The synapse model cells were loaded with 
Fura-2 AM in Hank’s buffered salt solution, and incubated for 1 h at 37 C. Intracellular calcium ion 
imaging was performed every 8 s using an epifluorescence microscope with air-cooled CCD camera 
and analyzed using AQUA COSMOM software. Fluorescence (emission at 510 nm) was recorded at  
8 s intervals for excitation at 340 and 380 nm, and the fluorescence ratio (R = I340nm/I380nm). The data 
were compared using Student’s t test. 
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3. Results and Discussion  
This  research  is  intended  to  promote  and  demonstrate  a  strategic  engineering  approach  for 
amplification of ligand-gated ion influx on post-synapse model cells. Initially, we investigated what 
happens  when GluR expression is simply  increased.  COS7 cells were  transfected with  expression 
plasmid encoding GluR and IRES-linked GFP marker. Owing to the function of the IRES sequence, 
GluR expression was correlated with the cellular fluorescence intensity derived from GFP. Figure 1 
shows the relationship between fluorescent intensity of GFP and immuno-staining under the cellular 
membrane-permeabilized  conditions.  Under  these  conditions,  the  antibody  could  bind  to  both 
intracellular GluR and GluR on the cell membrane surface, and the total fluorescent intensity reflects 
the GluR expression level. As the GFP fluorescence intensity correlates with the fluorescence intensity 
of immuno-staining, GFP can be used as a reporter of the level of GluR expression.  
Figure  1.  Relationship  between  fluorescent  intensity  of  GFP  and  total  GluR 
immunofluorescence. 
 
Figure 2 shows the relationship between the fluorescent intensity of GFP and the immuno-staining 
without  cellular  membrane-permeabilization.  Under  such  conditions,  fluorescence  intensity  from 
immuno-staining indicates the number of GluR molecules on the cell membrane. The data indicate that 
saturation occurred: the number of GluR on the cell membrane increased as GluR expression level 
increased up to a certain level, but then leveled off. In our previous study, we demonstrated that 
cellular responses on the model cells were saturated at a certain level of GluR expression [11]. These 
data suggest that the number of GluR on the cell membrane has reached the maximal value obtainable 
under  the  experimental  conditions.  In  the  case  of  higher  GluR-expressing  cells,  GluR  is  evenly 
displayed on cell surface and variation in cellular response can be reduced. Therefore, the reproducibility 
of cell-based sensors will be improved by using higher GluR-expressing cells. However, limitation of 
the number of GluR on the cell surface leads to a limitation on the maximal amplification of ion flux. 
Therefore, increasing the GluR expression level is not necessarily directly connected to amplification 
of the cellular responses.  
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Figure  2.  Relationship  between  fluorescent  intensity  of  GFP  (coexpressed  with  
GluR)  and  immunofluorescence  staining  of  GluR  on  cell  surface  (without  cellular  
membrane-permeabilization). 
 
Next, we tried to verify the usefulness of an alternative strategy: in increasing the ion flux per 
individual  receptor.  Maintenance  of  normal  membrane  potential  should  provide  driving  force  for 
sustained  ion  flux,  and  therefore,  we  coexpressed  a  voltage-gated  potassium  channel  potassium 
channel subunit, Kv1.3 [16] with GluR [18]. Kv1.3 should thus keep the membrane potential below 
reversal  potential  and  facilitate  enhanced  ion  flux  through  GluR.  In  the  coexpressing  cells,  the 
expression level of GluR was confirmed by the fluorescence of GFP and expression of Kv1.3 was 
confirmed by the fluorescence of DsRed (Figure 3). 
Figure  3.  Visualization  of  the  post-synapse  model  cell  expressing  GluR  and  Kv1.3, 
visualized by GFP and DsRed markers also present in the IRES vectors for the respective 
proteins. The scale bar represents 100 μm. 
 
The Ca
2+ influx of GluR-expressing cells or GluR-Kv1.3-cotransfected cells was analyzed using 
Fura-2 (Figure 4). Glutamate-triggered ion flux level increased when Kv1.3 was also present. This 
increase of ion flux was prevented by Kv1.3 blocker, margatoxin [19,20], suggesting that activation of 
Kv1.3  contributes  to  the  increased  ion  flux  through  GluR.  Without  Kv1.3  activation,  membrane 
potential is depolarized by the ion influx through GluR, leading to a reduction in the driving force of 
ion influx.  Sensors 2012, 12  1040 
 
Figure 4. Ion flux level of post-synapse model cells that express only GluR or coexpress 
GluR and Kv1.3 (2 mM glutamate application [open]: 2 mM glutamate application after  
10 nM margatoxin treatment [filled]). Ca
2+ influx was monitored by changes in fura-2 
340/380 nm ratio (R) normalized to baseline (Δ R/R0). The data represent the mean ±  SD 
with (*) indicating P < 0.01. 
 
4. Conclusions  
The  strategic  design  and  construction  of  post-synapse  model  cells  for  cellular  biosensing,  and 
potentially useful in drug screening, is described. In this study, we focused on obtaining a high S/N 
ratio for Ca
2+ influx through GluR. A simple increase of the expression level of receptors was found to 
be insufficient. However, coexpression with Kv1.3, as demonstrated here, allowed membrane potential 
to be kept below the reversal potential and resulted in enhanced ion flux responses through GluR. 
In conclusion, we demonstrate a strategy to increase the ion flux per individual receptor and improve 
the S/N ratio in ligand-gated ion channel-expressing cell-based biosensors. We also demonstrated that the 
reproducibility of cell-based sensors will be improved by using higher GluR-expressing cell. These 
approaches may provide a smart way to build post-synapse model cell-based biosensors for HTA  
drug discovery. 
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